Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial
Publisher: Time:2020-12-01Browse:1189 font size:【large】【middle】【small】
Please refer to the attachment for details.
/Files/file/20201201/20201201173215_2780.pdf